PARAP vs OSCR
Comparison between Paramount Global Conv Pfd (PARAP, Company) and Oscar Health Inc - Class A (OSCR, Company).
PARAP vs OSCR - Performance Comparison
Key Characteristics
Financial metrics and valuation ratios
Market Cap
Winner
PARAP
$8.99B
OSCR
$8.98B
Max Drawdown
Winner
PARAP
77.73%
OSCR
94.15%
Sharpe Ratio
PARAP
-0.81
Winner
OSCR
1.23
5Y Beta
PARAP
N/A
OSCR
1.02
Industry
PARAP
N/A
OSCR
Healthcare Plans
P/E Ratio
Winner
PARAP
-1320.95
OSCR
15.45
Forward P/E
PARAP
N/A
OSCR
588.24
PEG Ratio
PARAP
N/A
OSCR
0.05
Debt to Equity
PARAP
65.40%
Winner
OSCR
25.90%
Free Cash Flow Yield
PARAP
8.96%
Winner
OSCR
31.58%
P/S Ratio
Winner
PARAP
0.30
OSCR
0.68
P/B Ratio
Winner
PARAP
0.39
OSCR
5.66
PARAP vs OSCR - Historical Returns
Returns include dividend reinvestment.
1M
Winner
PARAP
+4.39%
OSCR
-10.35%
3M
PARAP
-19.91%
Winner
OSCR
+33.68%
6M
PARAP
-7.79%
Winner
OSCR
+127.94%
1Y
PARAP
-37.02%
Winner
OSCR
+84.04%
5Y(CAGR)
PARAP
N/A
OSCR
+12.98%
Max(CAGR)
PARAP
-32.88%
Winner
OSCR
-3.99%
PARAP vs OSCR - Annual Returns (2021 - 2026)
Returns include dividend reinvestment.
| Year | PARAP | OSCR |
|---|---|---|
| 2026 | N/A | +86.37% |
| 2025 | N/A | +6.05% |
| 2024 | -18.72% | +47.69% |
| 2023 | -6.69% | +271.95% |
| 2022 | -45.29% | -69.74% |
| 2021 | N/A | -77.44% |
PARAP vs OSCR Drawdown Comparison
The maximum drawdown for PARAP was -66.20%, occurring on Mar 5, 2024. This drawdown has not yet recovered.
The maximum drawdown for OSCR was -94.15%, occurring on Dec 21, 2022. This drawdown has not yet recovered.
The current PARAP drawdown is -61.42%. The current OSCR drawdown is -24.12%.
| Rank | PARAP | OSCR |
|---|---|---|
| #1 | -66.20% Mar 3, 2022 - Mar 5, 2024 | -94.15% Mar 10, 2021 - Dec 21, 2022 |
| #2 | -4.00% Feb 17, 2022 - Feb 25, 2022 | -10.92% Mar 3, 2021 - Mar 10, 2021 |
Correlation
Correlation between PARAP and OSCR is -0.27 which considered as a very weak or no correlation - the stocks move independently of each other.
-0.27
-101
Select Stocks to Compare
Popular: PARAP vs SPYOSCR vs SPY
More Comparisons
Compare with similar stocks